{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T12:04:06Z","timestamp":1725537846068},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,1]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Persistent renal dysfunction (PRD) has been reported in up to 22% of perinatally HIV-infected adolescents (PHAs) in the United States and Europe. There are limited data available on PRD among PHAs in resource-limited settings regarding access to antiretroviral therapy (ART) at more advanced HIV stages.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>We retrospectively described the prevalence of PRD and associated factors in a Thai PHA cohort. Inclusion criteria were current age \u226510 years old and at least 2 serum creatinine (Cr) measurements after ART initiation. Cr and urine examination were performed every 6\u201312 months. PRD was defined as having \u22652 measurements of low estimated glomerular filtration rate (eGFR); either &lt;60\u2009mL\/min\/1.73 m2 or elevated Cr for age and eGFR 60\u201389\u2009mL\/min\/1.73 m2, or proteinuria (dipstick proteinuria \u22651+). Factors associated with PRD were analyzed using a multivariate logistic regression analysis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>This study included 255 PHAs with median (interquartile range) age of 16.7 (14.5\u201318.8) and ART duration of 10.3 (7.1\u201312.4) years. Fifty-six percentage used boosted protease inhibitor (bPI)\u2013based regimens, and 63% used tenofovir disoproxil fumarate (TDF). The overall PRD prevalence was 14.1% [95% confidence interval (CI): 10.1\u201319.0]; low eGFR 6.7%, proteinuria 3.5% and both 3.9%. Among 109 users of TDF with bPI, 22.9% had PRD and 2.8% discontinued\/adjusted dosing of TDF because of nephrotoxicity. Factors associated with PRD were age 10\u201315 years old (adjusted odd ratio (aOR): 10.1, 95% CI: 4.1\u201325.2), male (aOR: 3.2, 95% CI: 1.4\u20137.7), CD4 nadir &lt;150 cells\/mm<jats:sup>3<\/jats:sup> (aOR: 2.6, 95% CI: 1.1\u20136.1) and use of TDF with bPI (aOR: 9.6, 95% CI: 3.2\u201328.9).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>PRD is common among PHAs. Almost one-fifth of adolescents using TDF with bPI had PRD. These adolescents should be a priority group for renal monitoring.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/inf.0000000000001684","type":"journal-article","created":{"date-parts":[[2017,7,18]],"date-time":"2017-07-18T17:23:33Z","timestamp":1500398613000},"page":"66-70","source":"Crossref","is-referenced-by-count":5,"title":["Prevalence of Persistent Renal Dysfunction in Perinatally HIV-infected Thai Adolescents"],"prefix":"10.1097","volume":"37","author":[{"given":"Torsak","family":"Bunupuradah","sequence":"first","affiliation":[{"name":"Division of Pediatric Nephrology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanit","family":"Phupitakphol","sequence":"additional","affiliation":[{"name":"Division of Pediatric Nephrology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiratchaya","family":"Sophonphan","sequence":"additional","affiliation":[{"name":"Division of Pediatric Nephrology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wasana","family":"Prasitsuebsai","sequence":"additional","affiliation":[{"name":"Division of Pediatric Nephrology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suvaporn","family":"Anugulruengkitt","sequence":"additional","affiliation":[{"name":"Division of Pediatric Nephrology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Watsamon","family":"Jantarabenjakul","sequence":"additional","affiliation":[{"name":"Division of Pediatric Nephrology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bunruan","family":"Sopa","sequence":"additional","affiliation":[{"name":"Division of Pediatric Nephrology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiat","family":"Ruxrungtham","sequence":"additional","affiliation":[{"name":"Division of Pediatric Nephrology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ankanee","family":"Chanakul","sequence":"additional","affiliation":[{"name":"Division of Pediatric Nephrology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thanyawee","family":"Puthanakit","sequence":"additional","affiliation":[{"name":"Division of Pediatric Nephrology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R2-20230913","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ijid.2013.12.011","article-title":"Long-term outcomes of HIV-infected children in Thailand: the Thailand Pediatric HIV Observational Database.","volume":"22","author":"Phongsamart","year":"2014","journal-title":"Int J Infect Dis"},{"key":"R3-20230913","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1742-6405-8-40","article-title":"Immunologic and virologic failure after first-line NNRTI-based antiretroviral therapy in Thai HIV-infected children.","volume":"8","author":"Bunupuradah","year":"2011","journal-title":"AIDS Res Ther"},{"key":"R4-20230913","doi-asserted-by":"crossref","first-page":"e58","DOI":"10.1097\/INF.0000000000000584","article-title":"Risk of first-line antiretroviral therapy failure in HIV-infected Thai children and adolescents.","volume":"34","author":"Bunupuradah","year":"2015","journal-title":"Pediatr Infect Dis J"},{"issue":"5 suppl 1","key":"R5-20230913","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1097\/INF.0000000000000663","article-title":"Metabolic and renal adverse effects of antiretroviral therapy in HIV-infected children and adolescents.","volume":"34","author":"Fortuny","year":"2015","journal-title":"Pediatr Infect Dis J"},{"key":"R6-20230913","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/INF.0b013e31819ca49a","article-title":"Incidence of persistent renal dysfunction in human immunodeficiency virus-infected children: associations with the use of antiretrovirals, and other nephrotoxic medications and risk factors.","volume":"28","author":"Andiman","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"R7-20230913","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1097\/INF.0b013e31827f4eff","article-title":"Tenofovir treatment duration predicts proteinuria in a multiethnic United States Cohort of children and adolescents with perinatal HIV-1 infection.","volume":"32","author":"Purswani","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"R8-20230913","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s40261-015-0287-5","article-title":"Tenofovir-associated nephrotoxicity in children with perinatally-acquired HIV infection: a single-centre cohort study.","volume":"35","author":"Lim","year":"2015","journal-title":"Clin Drug Investig"},{"key":"R9-20230913","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/1471-2431-13-75","article-title":"Renal abnormalities among HIV-infected, antiretroviral naive children, Harare, Zimbabwe: a cross-sectional study.","volume":"13","author":"Dondo","year":"2013","journal-title":"BMC Pediatr"},{"key":"R10-20230913","doi-asserted-by":"crossref","first-page":"172","DOI":"10.4103\/1319-2442.106364","article-title":"Prevalence of renal disease in Nigerian children infected with the human immunodeficiency virus and on highly active anti-retroviral therapy.","volume":"24","author":"Iduoriyekemwen","year":"2013","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"R11-20230913","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/INF.0000000000000571","article-title":"Review of tenofovir use in HIV-infected children.","volume":"34","author":"Aurpibul","year":"2015","journal-title":"Pediatr Infect Dis J"},{"key":"R12-20230913","first-page":"1925","article-title":"Guidelines for antiretroviral therapy in HIV-1 infected adults and adolescents: the recommendations of the Thai AIDS Society (TAS) 2008.","volume":"91","author":"Sungkanuparph","year":"2008","journal-title":"J Med Assoc Thai"},{"key":"R13-20230913","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2478\/abm-2010-0065","article-title":"Thai national guidelines for the use of antiretroviral therapy in pediatric HIV infection in 2010.","volume":"4","author":"Puthanakit","year":"2010","journal-title":"Asian Biomed"},{"key":"R16-20230913","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0031-3955(16)36251-4","article-title":"The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents.","volume":"34","author":"Schwartz","year":"1987","journal-title":"Pediatr Clin North Am"},{"key":"R17-20230913","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1681\/ASN.2008030287","article-title":"New equations to estimate GFR in children with CKD.","volume":"20","author":"Schwartz","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"R18-20230913","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1097\/QAD.0b013e328356480d","article-title":"Comparisons between validated estimated glomerular filtration rate equations and isotopic glomerular filtration rate in HIV patients.","volume":"26","author":"Praditpornsilpa","year":"2012","journal-title":"AIDS"},{"key":"R19-20230913","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.cca.2008.03.021","article-title":"Evaluation of the Bayer microalbumin\/creatinine urinalysis dipstick.","volume":"393","author":"Wilde","year":"2008","journal-title":"Clin Chim Acta"},{"key":"R21-20230913","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1086\/655681","article-title":"Systematic review and meta-analysis: renal safety of tenofovir disoproxil fumarate in HIV-infected patients.","volume":"51","author":"Cooper","year":"2010","journal-title":"Clin Infect Dis"},{"key":"R22-20230913","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1089\/aid.2006.22.744","article-title":"Urinary beta2-microglobulin as a possible sensitive marker for renal injury caused by tenofovir disoproxil fumarate.","volume":"22","author":"Gatanaga","year":"2006","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R23-20230913","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s40121-014-0056-4","article-title":"Protease inhibitors and renal function in patients with HIV infection: a systematic review.","volume":"4","author":"Bagnis","year":"2015","journal-title":"Infect Dis Ther"},{"key":"R24-20230913","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1097\/INF.0b013e31818c8d2c","article-title":"Tenofovir use in human immunodeficiency virus-1-infected children in the United kingdom and Ireland.","volume":"28","author":"Riordan","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"R25-20230913","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1471-2334-12-18","article-title":"Renal function in HIV-infected children and adolescents treated with tenofovir disoproxil fumarate and protease inhibitors.","volume":"12","author":"Pontrelli","year":"2012","journal-title":"BMC Infect Dis"},{"key":"R26-20230913","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/ckj\/sfv015","article-title":"Atazanavir nephrotoxicity.","volume":"8","author":"Hara","year":"2015","journal-title":"Clin Kidney J"},{"key":"R27-20230913","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3109\/00365548.2012.712213","article-title":"Incidence of renal toxicity in HIV-infected, antiretroviral-na\u00efve patients starting tenofovir\/emtricitabine associated with efavirenz, atazanavir\/ritonavir, or lopinavir\/ritonavir.","volume":"45","author":"Calza","year":"2013","journal-title":"Scand J Infect Dis"},{"key":"R28-20230913","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3947\/ic.2015.47.4.239","article-title":"The incidence and clinical characteristics of acute serum creatinine elevation more than 1.5\u2009mg\/dL among the patients treated with tenofovir\/emtricitabine-containing HAART regimens.","volume":"47","author":"Jin","year":"2015","journal-title":"Infect Chemother"},{"key":"R29-20230913","first-page":"1","article-title":"Renal function recovery and HIV viral suppression following tenofovir discontinuation for renal impairment.","volume":"5","author":"Romo","year":"2014","journal-title":"J AIDS Clin Res"},{"key":"R30-20230913","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s10157-013-0817-5","article-title":"Prevalence of renal disease within an urban HIV-infected cohort in northern Italy.","volume":"18","author":"Calza","year":"2014","journal-title":"Clin Exp Nephrol"},{"key":"R31-20230913","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1007\/s00467-011-2097-1","article-title":"Chronic kidney disease associated with perinatal HIV infection in children and adolescents.","volume":"27","author":"Purswani","year":"2012","journal-title":"Pediatr Nephrol"},{"key":"R32-20230913","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1097\/QAD.0000000000000628","article-title":"Nonalbumin proteinuria predominates in biopsy-proven tenofovir nephrotoxicity.","volume":"29","author":"Sise","year":"2015","journal-title":"AIDS"},{"key":"R33-20230913","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1097\/INF.0b013e31825eb0ad","article-title":"HIV and hepatitis B coinfection among perinatally HIV-infected Thai adolescents.","volume":"31","author":"Aurpibul","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"R34-20230913","doi-asserted-by":"crossref","first-page":"e602","DOI":"10.1016\/j.ijid.2009.09.002","article-title":"Human immunodeficiency virus-hepatitis C virus co-infection in pregnant women and perinatal transmission to infants in Thailand.","volume":"14","author":"Ngo-Giang-Huong","year":"2010","journal-title":"Int J Infect Dis"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00006454-201801000-00010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T18:14:50Z","timestamp":1694628890000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006454-201801000-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000001684","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]}}}